27 Sep 2022
IDTechEx Report Examines Device Trends in Remote Patient Monitoring
Remote patient monitoring (RPM), referring to the use of technology to measure and transmit physiologic data beyond traditional healthcare settings, has emerged as a promising solution to drive down healthcare costs while maintaining a high standard of care for patients.
07 Oct 2021
Oncology Is a Major Focus for Many AI Drug Discovery Companies
The application of artificial intelligence (AI) in the drug discovery process is promising to drastically cut down timelines and costs of bringing new therapies to patients.
18 Aug 2021
AI in Drug Discovery Requires Extensive Chemical Libraries
AI in drug discovery is a field that has received an immense increase in interest, uptake, and investment over the past year due to the COVID-19 pandemic. While lockdowns forced everyone around the world to explore virtual ways of working, the biopharma industry faced the additional task of quickly developing new drugs for the treatment of COVID-19. Enter the application of AI in drug discovery - a technology that promises to drastically cut down timelines and costs, and potentially, develop safer and more efficacious drugs.
10 Jun 2021
AI has been successfully applied to speed up virtual screening, de novo drug discovery, and can be utilized to optimize compounds to have drug-like properties. Processes that typically take several years can be reduced to a matter of months.
09 Apr 2021
抗菌技術 - どのように機能するのか？
Antimicrobial technologies such as coatings and textiles containing silver and copper are helping people during the COVID-19 pandemic by ensuring that whatever they touch, whether that is a door handle or their own mask, is free from live SARS-CoV-2 particles. But how exactly do these antimicrobial technologies work?
09 Mar 2021
Innovations in Antimicrobials: New Methods to Eliminate Microbes
Today, antimicrobial technologies are used around the world in response to the COVID-19 pandemic. Surfaces and products protected by antimicrobial technology can continuously inactivate and kill harmful microorganisms such as the SARS-CoV-2 virus. In this article, IDTechEx highlights three innovative start-ups that are developing next-generation antimicrobial technologies.
11 Feb 2021
COVID-19 Driving Unprecedented Growth for Antimicrobial Industry
COVID-19 is driving 3- and 4-digit growth for antimicrobial companies - this market has received significant attention from governments, industry, and even consumers over the past year (2020) due to the technology's potential to address transmission of COVID-19.
07 Dec 2020
COVID-19 Brings Unprecedented Shifts in Healthcare Technology Adoption
At IDTechEx, we cover emerging technologies and industry trends, and the COVID-19 pandemic has had a direct or indirect impact on all of them. In this article we will describe some of the key roles that these technologies have played in 2020.
17 Nov 2020
Opportunities in Bioelectronic Medicine - Recent Progress
IDTechEx finds significant progress for companies developing non-invasive peripheral nerve stimulation technologies
22 Sep 2020
IDTechEx forecasts that flexible electronics in cardiac monitoring, deployed in electronic skin patches and electronic textiles, will be a $2 billion market in the year 2030.
20 Aug 2020
Skin Sensors Enable Personalized Skin Care
IDTechEx have released a new research report, "Skin Sensors 2020- 2030: Technologies, Markets, Players, Forecasts".
23 Jul 2020
Skin Analysis Technologies Market to Reach $275 Million by 2030
With a surface area of up to 2 square meters, skin is the largest organ of the human body. Skin acts as an outer covering and barrier - not only is skin health crucial to the overall health of an individual, but skin appearance has significant societal impact as well (body image, communication, etc.).